There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
3 responses
3,336 views
0 reactions
|
by tomdriedonks
08-06-2015, 05:03 AM
|
|||
|
4 responses
5,001 views
0 reactions
|
by DNA_Dan
08-03-2015, 09:28 AM
|
|||
|
2 responses
4,267 views
0 reactions
|
by pmiguel
08-03-2015, 08:24 AM
|
|||
|
4 responses
2,370 views
0 reactions
|
by Johnny99
08-03-2015, 12:57 AM
|
|||
|
1 response
2,627 views
0 reactions
|
08-02-2015, 12:25 PM
|
|||
|
0 responses
1,360 views
0 reactions
|
08-01-2015, 09:09 PM
|
|||
|
1 response
3,140 views
0 reactions
|
07-29-2015, 11:45 AM
|
|||
|
3 responses
1,419 views
0 reactions
|
07-28-2015, 02:05 AM
|
|||
|
2 responses
4,765 views
0 reactions
|
07-23-2015, 10:06 PM
|
|||
|
5 responses
7,399 views
0 reactions
|
by kerplunk412
07-23-2015, 05:03 PM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
